Diana Julie Leeming
Head of Fibrosis
Scientific Leadership
Nordic Bioscience
Denmark
Biography
Diana Julie Leeming joined Nordic Bioscience in 2004 and assumed the position as Head of Fibrosis in 2009. Diana is responsible for guiding a team of 15 people working on the Protein Fingerprint Technology including development, characterization and lab production of enzyme-linked immunosorbent assays (ELISAs) for serological biomarker assessments and design of animal studies. Diana has been a part of most research and development processes and is deeply involved in the development and validation of biomarkers, including discovery, project design, establishment of proof-of-concept, patenting, assay characterization, feasibility, product development, and upscaling of production. Diana also works on large as wells as small RnD and Fee-for-Service projects for clients.
Research Interest
Protein
